Project Details
Description
Anterior cruciate ligament (ACL) injuries can cause serious disability
and degeneration of the knee joint. Primary repair is not efficacious
and currently available grafts or prostheses are not ideally suited for
ACL reconstruction. Tissue engineering, an emerging technology
combining resorbable scaffolds, cells, and modulators of cell behavior,
may revolutionize treatment of musculoskeletal soft tissue injuries by
providing alternatives to biological grafts and permanent synthetic
prostheses. The three specific aims of this study are to understand and
improve neoligament formation by utilizing tissue engineering
strategies: Aim number 1: Test the hypothesis that the quality of the
neoligament tissue is directly related to the strength retention profile
of the scaffold, by comparing the efficacy of 3 types of resorbable
scaffolds with similar biocompatibility but different strength
retention: collagen scaffolds (rapid strength loss), polyarylate
scaffolds (intermediate strength loss), and polycarbonate scaffolds
(prolonged strength retention). Aim number 2: Test the hypothesis that
neoligament formation is accelerated by pre-seeding the scaffold with
fibroblasts, by comparing the relative efficacy of unseeded scaffolds
vs. 'ligament analogs' pre-seeded in vitro with skin or ACL fibroblasts.
These fibroblasts are known to have different healing potentials. Aim
number 3: Test the hypothesis that neoligament formation is enhanced by
modulating the behavior of local repair cells, by incorporating specific
polypeptide growth factors (known to influence normal tissue repair)
into the ACL reconstruction scaffolds.
Completion of these studies in a well-established animal model will lead
to a better understanding of the mechanisms of neoligament formation in
response to resorbable scaffolds, seeded cells, and modulators of cell
behavior. This knowledge may provide a 'blueprint' for development of
a novel approach for reconstruction of the ACL and other non-healing
musculoskeletal soft tissues.
Status | Finished |
---|---|
Effective start/end date | 5/1/99 → 4/30/05 |
Funding
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $48,107.00
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $278,334.00
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $270,635.00
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $46,706.00
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $286,264.00
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: $294,435.00
ASJC
- Medicine(all)
- Biotechnology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.